Skip to Content
<p data-pm-slice="1 1 []">Crinetics Pharmaceuticals is now a Vertex Pharmaceuticals company. We announced the agreement earlier this year to further advance our programs and support patients.</p>

Search Results

Results for: ""

Everyday Advocacy: The Small Moments That Shape a Patient’s Journey

Jacqui Kirby Chief Corporate Affairs Officer Ask a person living with an endocrine condition where advocacy happens. They usually won’t...

READ MORE →

A New Chapter for Acromegaly Care in the European Union

Fabian SchmidtVice President, Head of Medical Affairs – Europe Acromegaly presents a significant challenge for patients and the clinicians who...

READ MORE →

NANETS 2025: Reimagining Treatment for Carcinoid Syndrome

Tom BeveridgeGlobal Product Lead, Paltusotine for Carcinoid Syndrome For individuals living with carcinoid syndrome (CS), a condition caused by neuroendocrine...

READ MORE →

A New Era in Acromegaly Care: Putting Patients at the Center

Isabel KalofonosChief Commercial Officer, Crinetics Pharmaceuticals For years, people living with acromegaly have navigated a care landscape that has remained...

READ MORE →

Patient Focused Drug Development

Stephanie KallayDirector of Patient Advocacy Partners in Progress: How Patient Insights Drive Innovation At Crinetics, our mission has always been...

READ MORE →

Understanding the Role of IGF-1 in Managing Acromegaly

Dr. Alan KrasnerChief Endocrinologist If you are living with acromegaly, you’ve likely heard your healthcare provider talk about “IGF-1” during...

READ MORE →

Acromegaly Awareness Day: Our Support to the Community Today and Beyond

Dana Pizzuti, M.D.Chief Medical and Development Officer Each year on November 1, the acromegaly community comes together to observe Acromegaly...

READ MORE →

Celebrating Women’s Leadership: Crinetics’ Commitment to Scientific and Strategic Excellence

Jacqui KirbyChief Corporate Affairs Officer As I reflect on Women’s History Month, I find myself reflecting on the inspiring leaders...

READ MORE →

Podcast: Work Continues on New Drugs/Therapies for Pituitary Patients

We wondered how this critically important work for pituitary patients was affected by the pandemic. Dr. Struthers gives us an...

READ MORE →